Related Experiment Video
Updated: Mar 26, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
The MOGE(S) classification : A TNM-like classification for cardiomyopathies
E Şahan1, S Şahan2, M Karamanlıoğlu3
1Cardiology, Atatürk Pulmonary Disease and Thorax Surgery Research Hospital, Ankara, Turkey. ekremsahan@hotmail.com.
Insights
Cardiomyopathy, a heart muscle disease, is now classified using the MOGE(S) system, which incorporates genetic factors. This genotype-phenotype approach aids in diagnosing and managing cardiomyopathies like cancer.
Area of Science:
- Cardiology
- Genetics
- Medical Diagnostics
Background:
- Cardiomyopathy affects heart muscle due to genetic defects, injury, or infiltration.
- Traditional classifications (dilated, restrictive, hypertrophic) lack genetic considerations.
- Genetic basis of diseases, including cardiomyopathies, is increasingly understood.
Purpose of the Study:
- Introduce the MOGE(S) system for classifying cardiomyopathies.
- Highlight the importance of genetic basis in cardiomyopathy diagnosis and management.
- Propose MOGE(S) as a genotype-phenotype nosology system.
Main Methods:
- Review traditional cardiomyopathy definitions.
- Incorporate the World Heart Federation's 2013 proposal.
- Describe the MOGE(S) system's structure and function.
Main Results:
- The MOGE(S) system integrates genetic and phenotypic information.
- It offers a descriptive classification for cardiomyopathies.
- The system is analogous to the TNM classification for malignancy.
Conclusions:
- The MOGE(S) system provides a comprehensive approach to cardiomyopathies.
- It facilitates improved diagnosis, management, and treatment strategies.
- Genotype-phenotype classification is crucial for modern cardiomyopathy care.
Abstract:
Cardiomyopathy is a disease of the heart muscle resulting from genetic defects, cardiac myocyte injury, or infiltration of the myocardium. Cardiomyopathies are traditionally defined as dilated, restrictive, and hypertrophic cardiomyopathy. Today, the genetic basis of most diseases has been clearly defined and has influenced the approach to familial diseases such as cardiomyopathies. Traditional definitions of cardiomyopathies, such as those by the American Heart Association and the European Society of Cardiology, do not consider the genetic basis of cardiomyopathies. In 2013, the World Heart Federation added the genetic basis of cardiomyopathies and proposed a descriptive genotype-phenotype nosology system termed "MOGE(S)." The MOGE(S) system resembles the TNM classification system for malignancy, and therefore it can be useful for the diagnosis, management, and treatment of cardiomyopathies in a similar manner to cancer management.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests

